Pathstone Holdings
CLB icon

Pathstone Holdings’s Core Laboratories CLB Stock Holding History

Pathstone Holdings’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
10,547
+197
+2% +$2.81K ﹤0.01% 2278
2026
Q1 		$174K Buy
+10,350
New +$185K ﹤0.01% 2127
2025
Q4 		– Sell
-10,065
Closed -$124K – 2259
2025
Q3 		$124K Buy
+10,065
New +$118K ﹤0.01% 2253
2025
Q2 		– Sell
-15,169
Closed -$227K – 2205
2025
Q1 		$227K Sell
15,169
-7,425
-33% -$124K ﹤0.01% 2033
2024
Q4 		$391K Sell
22,594
-1,489
-6% -$28.7K ﹤0.01% 1831
2024
Q3 		$446K Buy
24,083
+399
+2% +$8.01K ﹤0.01% 1785
2024
Q2 		$481K Buy
23,684
+11,748
+98% +$208K ﹤0.01% 1718
2024
Q1 		$204K Sell
11,936
-787
-6% -$12.4K ﹤0.01% 2137
2023
Q4 		$225K Buy
+12,723
New +$256K ﹤0.01% 2006

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pathstone Holdings's CLB Position: Q2 2026 in Review

Pathstone Holdings increased its Core Laboratories (CLB) stake by 1.9% in Q2 2026, buying an estimated $2.81K and bringing the position to 10,547 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

Pathstone Holdings first reported a position in CLB in Q4 2023 and has held it in 9 quarters since. The position peaked at $481K in Q2 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Pathstone Holdings held 10,547 shares of Core Laboratories worth $123K as of Q2 2026.
  • Pathstone Holdings bought 197 Core Laboratories shares in Q2 2026, an estimated $2.81K.
  • Core Laboratories made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2278 holding.
  • Pathstone Holdings first reported a position in Core Laboratories in Q4 2023 and has held it in 9 quarters since.
  • Pathstone Holdings's Core Laboratories position peaked at $481K in Q2 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.